SEARCH

SEARCH BY CITATION

References

  • Arcelli, D., Farina, A., Cappuzzello, C., Bresin, A., De Sanctis, P., Perolo, A., Prandstraller, D., Valentini, D., Zucchini, C., Priori, S., et al. (2010). Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening. Prenat. Diagn. 30, 229234.
  • Benevolo, M., Mottolese, M., Tremante, E., Rollo, F., Diodoro, M.G., Ercolani, C., Sperduti, I., Lo Monaco, E., Cosimelli, M., and Giacomini, P. (2011). High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J. Transl. Med. 9, 184.
  • Bossard, C., Bezieau, S., Matysiak-Budnik, T., Volteau, C., Laboisse, C.L., Jotereau, F., and Mosnier, J.F. (2012). HLA-E/beta2 microglobulin over-expression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression. Int. J. Cancer 131, 855863.
  • Braud, V.M., Allan, D.S.J., O'callaghan, C.A., Söderström, K., D'andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H., et al. (1998). HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795799.
  • Braud, V.M., Allan, D.S.J., and Mcmichael, A.J. (1999). Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11, 100108.
  • Carrega, P., Pezzino, G., Queirolo, P., Bonaccorsi, I., Falco, M., Vita, G., Pende, D., Misefari, A., Moretta, A., Mingari, M.C., et al. (2009). Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells. PLoS ONE 4, e8132.
  • De Kruijf, E.M., Sajet, A., Van Nes, J.G., Natanov, R., Putter, H., Smit, V.T., Liefers, G.J., Van Den Elsen, P.J., Van De Velde, C.J., and Kuppen, P.J. (2010). HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients. J. Immunol. 185, 74527459.
  • Degenhardt, Y., Huang, J., Greshock, J., Horiates, G., Nathanson, K., Yang, X., Herlyn, M., and Weber, B. (2010). Distinct MHC gene expression patterns during progression of melanoma. Genes Chromosom. Cancer 49, 144154.
  • Derré, L., Corvaisier, M., Charreau, B., Moreau, A., Godefroy, E., Moreau-Aubry, A., Jotereau, F., and Gervois, N. (2006). Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J. Immunol. 177, 31003107.
  • Fisher, P.B. (2005). Is mda-7/IL-24 a “magic bullet” for cancer? Cancer Res. 65, 1012810138.
  • Fruci, D., Benevolo, M., Cifaldi, L., Lorenzi, S., Lo Monaco, E., Tremante, E., and Giacomini, P. (2012). Major histocompatibility complex class I and tumour immuno-evasion: how to fool T cells and natural killer cells at one time. Curr. Oncol. 19, 3941.
  • Garcia, P., Llano, M., Heredia, A.B., Willberg, C.B., Caparros, E., Aparicio, P., Braud, V.M., and Lopez-Botet, M. (2002). Human T cell receptor-mediated recognition of HLA-E. Eur. J. Immunol. 32, 936944.
  • Giacomini, P., Segatto, O., and Natali, P.G. (1987). Multiple epitope recognition: an approach to improved radioimmunodetection of tumor associated antigens. Int. J. Cancer 39, 729736.
  • Giacomini, P., Fraioli, R., Cuomo, M., and Natali, P.G. (1992). Membrane compartmentalization of melanosomal gp75. J. Invest. Dermatol. 98, 340342.
  • Giacomini, P., Giorda, E., Pera, C., and Ferrara, G.B. (2001). An ID card for tumour cell lines: HLA typing can help. Lancet Oncol. 2, 658.
  • Giorda, E., Sibilio, L., Martayan, A., Moretti, S., Venturo, I., Mottolese, M., Ferrara, G.B., Cappellacci, S., Eibenschutz, L., Catricalà, C., et al. (2003). The antigen processing machinery of Human Leukocyte Antigens: linked patterns of gene expression in neoplastic cells. Cancer Res. 63, 41194127.
  • Houghton, A.N., Thomson, T.M., Gross, D., Oettgen, H.F., and Old, L.J. (1984). Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human γ-interferon. J. Exp. Med. 160, 255269.
  • Hurks, H.M., Valter, M.M., Wilson, L., Hilgert, I., Van Den Elsen, P.J., and Jager, M.J. (2002). Uveal melanoma: no expression of HLA-G. Invest. Ophthalmol. Vis. Sci. 42, 30813084.
  • John, T., Black, M.A., Toro, T.T., Leader, D., Gedye, C.A., Davis, I.D., Guilford, P.J., and Cebon, J.S. (2008). Predicting clinical outcome through molecular profiling in stage III melanoma. Clin. Cancer Res. 14, 51735180.
  • Kren, L., Slaby, O., Muckova, K., Lzicarova, E., Sova, M., Vybihal, V., Svoboda, T., Fadrus, P., Lakomy, R., Vanhara, P., et al. (2011). Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance? Neuropathology 31, 129134.
  • Lagonigro, M.S., De Cecco, L., Carninci, P., Di Stasi, D., Ranzani, T., Rodolfo, M., and Gariboldi, M. (2004). CTAB-urea method purifies RNA from melanin for cDNA microarray analysis. Pigment Cell Res. 17, 312315.
  • Lakshmikanth, T., Burke, S., Ali, T.H., Kimpfler, S., Ursini, F., Ruggeri, L., Capanni, M., Umansky, V., Paschen, A., Sucker, A., et al. (2009). NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J. Clin. Invest. 119, 12511263.
  • Lanier, L.L. (2005). NK cell recognition. Annu. Rev. Immunol. 23, 225274.
  • Levy, E.M., Bianchini, M., Von Euw, E.M., Barrio, M.M., Bravo, A.I., Furman, D., Domenichini, E., Macagno, C., Pinsky, V., Zucchini, C., et al. (2008). Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer. Int. J. Oncol. 32, 633641.
  • Lo Monaco, E., Sibilio, L., Melucci, E., Tremante, E., Suchànek, M., Horejsi, V., Martayan, A., and Giacomini, P. (2008). HLA-E: strong association with βm and surface expression in the absence of HLA class I signal sequence-derived peptides. J. Immunol. 181, 54425450.
  • Lo Monaco, E., Tremante, E., Cifaldi, L., Fruci, D., and Giacomini, P. (2010). HLA-E and the origin of immunogenic self HLA epitopes. Mol. Immunol. 47, 16611662; author reply 1163-4.
  • Lo Monaco, E., Tremante, E., Cerboni, C., Melucci, E., Sibilio, L., Zingoni, A., Nicotra, M.R., Natali, P.G., and Giacomini, P. (2011). Human Leukocyte Antigen E contributes to protect tumor cells from lysis by natural killer cells. Neoplasia 13, 822830.
  • Mandruzzato, S., Callegaro, A., Turcatel, G., Francescato, S., Montesco, M.C., Chiarion-Sileni, V., Mocellin, S., Rossi, C.R., Bicciato, S., Wang, E., et al. (2006). A gene expression signature associated with survival in metastatic melanoma. J. Transl. Med. 4, 50.
  • Marìn, R., Ruiz-Cabello, F., Pedrinaci, S., Mendez, R., Jimenez, P., Geraghty, D.E., and Garrido, F. (2003). Analysis of HLA-E expression in human tumors. Immunogenetics 54, 767775.
  • Mischiati, C., Natali, P.G., Sereni, A., Sibilio, L., Giorda, E., Cappellacci, S., Nicotra, M.R., Mariani, G., Di Filippo, F., Catricalà, C., et al. (2006). cDNA array profiling of melanomas and paired melanocyte cultures. J. Cell. Physiol. 207, 697705.
  • Natali, P.G., Cordiali-Fei, P., Cavaliere, R., Di Filippo, F., Quaranta, V., Pellegrino, M.A., and Ferrone, S. (1981). Ia-like antigens on freshly explanted human melanoma. Clin. Immunol. Immunopathol. 19, 250259.
  • Palmisano, G.L., Contardi, E., Morabito, A., Gargaglione, V., Ferrara, G.B., and Pistillo, M.P. (2005). HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines. Hum. Immunol. 66, 112.
  • Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F.A., Avril, M.F., Dausset, J., Guillet, J.G., and Carosella, E.D. (1998). HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc. Natl Acad. Sci. 95, 45104515.
  • Perussia, B., Ramoni, C., Anegon, I., Cuturi, M.C., Faust, J., and Trinchieri, G. (1987). Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat. Immun. Cell Growth Regul. 6, 171188.
  • Ravindranath, M.H., Taniguchi, M., Chen, C.W., Ozawa, M., Kaneku, H., El-Awar, N., Cai, J., and Terasaki, P.I. (2010). HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. Mol. Immunol. 47, 11211131.
  • Rodgers, J., and Cook, R. (2005). MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5, 459471.
  • Romagnani, C., Pietra, G., Falco, M., Millo, E., Mazzarino, P., Biassoni, R., Moretta, A., Moretta, L., and Mingari, M.C. (2002). Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc. Natl Acad. Sci. 99, 1132811333.
  • Shimizu, Y., and Demars, R. (1989). Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J. Immunol. 142, 33203328.
  • Simon, R., Lam, A., Li, M.C., Ngan, M., Menenzes, S., and Zhao, Y. (2007). Analysis of gene expression data using BRB-ArrayTools. Cancer Inform. 3, 1117.
  • Speiser, D.E., Pittet, M.J., Valmori, D., Dunbar, R., Rimoldi, D., Liénard, D., Macdonald, H.R., Cerottini, J.C., Cerundolo, V., and Romero, P. (1999). In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 190, 775782.
  • Tremante, E., Ginebri, A., Lo Monaco, E., Frascione, P., Di Filippo, F., Terrenato, I., Benevolo, M., Mottolese, M., Pescarmona, E., Visca, P., et al. (2012). Melanoma molecular classes in the post-genomic era. Lancet Oncol. 13, e205e211.
  • Van Endert, P. (2011). Post-proteasomal and proteasome-independent generation of MHC class I ligands. Cell. Mol. Life Sci. 68, 15531567.
  • Zaidi, M.R., Davis, S., Noonan, F.P., Graff-Cherry, C., Hawley, T.S., Walker, R.L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H.A., et al. (2011). Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature 469, 548553.